Filing Details
- Accession Number:
- 0001264124-12-000076
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-02 19:45:17
- Reporting Period:
- 2012-03-01
- Filing Date:
- 2012-03-02
- Accepted Time:
- 2012-03-02 19:45:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
881464 | Amylin Pharmaceuticals Inc | AMLN | Pharmaceutical Preparations (2834) | 330266089 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1236397 | Daniel Bradbury | 9360 Towne Centre Dr San Diego CA 92121 | President & Chief Executive Of | No | Yes | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-03-01 | 1,539 | $17.11 | 62,912 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-03-01 | 4,167 | $0.00 | 58,745 | No | 4 | D | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | D | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Phantom Stock-Deferred Compensation | Acquisiton | 2012-03-01 | 4,167 | $0.00 | 4,167 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
137,917 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 46,545 | Indirect | By GRAT |
Common Stock | 13,456 | Indirect | Indirect-401k |
Common Stock | 6,445 | Indirect | by ESOP |
Common Stock | 33,283 | Indirect | by Trust |
Common Stock | 23,923 | Indirect | by Trust-1 |
Footnotes
- Sale of common shares to satisfy reporting person's income tax withholding obligations due upon vesting of restricted stock units.
- Includes 2,273 shares recently acquired under the Company's Employee Stock Purchase Plan.
- These shares were previously reported as indirectly beneficially owned by The Bradbury Family Trust but were contributed to a grantor retained annuity trust on July 27, 2010.
- These shares fully vested four years from the date of the reporting person's participation in the ESOP in four equal annual installments and are generally distributed upon termination of employment.
- Shares held by the Bradbury Gift Trust, of which the reporting person's minor children are beneficiaries.
- Represents shares of phantom stock acquired upon vesting of restricted stock units. The reporting person deferred receipt of common shares issuable upon such vesting and instead received shares of phantom stock pursuant to Amylin's Deferred Compensation Plan.
- Shares of phantom stock are generally distributed to the reporting person in the form of Amylin common stock following termination of employment in accordance with the reporting person's deferral elections.